Companies / Lebanon
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Drug Prices In Lebanon Still Courting Controversy
April 2006 | Market Trend AnalysisSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Drug pricing in Lebanon remains a contentious issue with the cost of medicines among the highest in the region. High retail prices in Lebanon are largely the result of the poor enforcement of regulations. The existing drug import rules do include price negotiations, with the Lebanese authorities granting import permits only after the approval of a given supplier's pricing levels. However, some industry observers claim the problem lies with retailers, some of which have margins of